MedTrace Logo

Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients

NCT00655226 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2011-08-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether cognitive behavioral therapy (CBT) is effective in the prevention of depression during interferon and ribavirin treatment for hepatitis C infection.

Conditions

  • Hepatitis C
  • Depressive Disorder, Major
  • Depressive Disorder
  • Depression
  • HIV Infections

Interventions

BEHAVIORAL

Hepatitis C educational support groups

Hepatitis C educational support groups

BEHAVIORAL

Cognitive Behavioral Therapy skills based group sessions

Eight CBT group sessions tailored for hepatitis C patients conducted by a clinical psychologist: 3 sessions conducted prior to IFN/ribavirin initiation, 1 session the day of IFN/ribavirin initiation, and 4 sessions during IFN/ribavirin treatment.

Sponsors & Collaborators

Principal Investigators

  • Thomas G McGinn, MD, MPH · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00655226 on ClinicalTrials.gov